Hospitalisation Utilisation and Costs in Schizophrenia Patients in Finland before and after Initiation of Risperidone Long-Acting Injection

Table 4

RLAI dose distributions in patients beginning with RLAI, and every 6 months onwards. for each patient, the last known observation on dose was carried forward to the time point. Two patients were excluded from the analysis of dose changes at later time points because of missing information.

	At treatment beginning	6 months later	12 months later	18 months later	24 months later
N (patients)	177 (100%)	132 (100%)	121 (100%)	87 (100%)	45 (100%)
25 mg	134 (76%)	41 (31%)	33 (27%)	24 (28%)	17 (38%)
37.5 mg	24 (14%)	40 (30%)	35 (29%)	26 (30%)	13 (29%)
50 mg	19 (11%)	48 (36%)	49 (40%)	34 (39%)	14 (31%)
62.5 mg	0	1 (1%)	1 (1%)	0	0
75 mg	0	2 (2%)	3 (2%)	3 (3%)	1 (2%)
100 mg	0	0	0	0	0